- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/68 - Melanocyte-stimulating hormone [MSH]
Patent holdings for IPC class C07K 14/68
Total number of patents in this class: 120
10-year publication summary
|
7
|
8
|
7
|
5
|
5
|
1
|
2
|
6
|
8
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Endevica bio, Inc. | 67 |
29 |
| The Arizona Board of Regents on Behalf of the University of Arizona | 2339 |
12 |
| Palatin Technologies, Inc. | 59 |
8 |
| Novo Nordisk A/S | 2290 |
8 |
| Rhythm Pharmaceuticals, Inc. | 99 |
6 |
| Ipsen Pharma S.A.S. | 371 |
5 |
| Board of Regents, The University of Texas System | 6231 |
4 |
| H. Lee Moffitt Cancer Center and Research Institute, Inc. | 1054 |
4 |
| Intezyne Technologies, Inc. | 50 |
4 |
| Provincial Health Services Authority | 203 |
4 |
| Stc.unm | 656 |
4 |
| TXP Pharma GmbH | 11 |
4 |
| Genzyme Corporation | 1381 |
3 |
| The University of British Columbia | 1569 |
3 |
| The Regents of the University of Colorado, a body corporate | 2860 |
2 |
| Trustees of Tufts College | 1007 |
2 |
| Tufts Medical Center, Inc. | 239 |
2 |
| The Regents of the University of Michigan | 5103 |
1 |
| The Trustees of the University of Pennsylvania | 4453 |
1 |
| Aileron Therapeutics, Inc. | 78 |
1 |
| Other owners | 13 |